Literature DB >> 19696234

Galectin-3 regulates peritoneal B1-cell differentiation into plasma cells.

Felipe L Oliveira1, Roger Chammas, Lauremília Ricon, Marise L Fermino, Emerson S Bernardes, Daniel K Hsu, Fu-Tong Liu, Radovan Borojevic, Márcia C El-Cheikh.   

Abstract

Extracellular galectin-3 participates in the control of B2 lymphocyte migration and adhesion and of their differentiation into plasma cells. Here, we analyzed the role of galectin-3 in B1-cell physiology and the balance between B1a and B1b lymphocytes in the peritoneal cavity. In galectin-3(-/-) mice, the total number of B1a lymphocytes was lower, while B1b lymphocyte number was higher as compared to wild-type mice. The differentiation of B1a cells into plasma cells was associated with their abnormal adhesion and location on the mesentery. The B220 and CD43, constitutively expressed by B1 lymphocytes, were respectively up- and downregulated in galectin-3(-/-) mice. Mononuclear cells were strongly adhered to the mesenteric membranes of both CD43(-/-) and galectin-3(-/-) mice, but in contrast to CD43(-/-) mice, the accumulation of B1 cells in peritoneal membranes in galectin-3(-/-) mice was accompanied by their functional differentiation into plasma cells. We have shown that in the absence of galectin-3, B1-cell differentiation into plasma cells is favored and the dynamic equilibrium of B1-cell populations in the peritoneum is maintained through a compensatory increase in B1b lymphocytes.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19696234     DOI: 10.1093/glycob/cwp120

Source DB:  PubMed          Journal:  Glycobiology        ISSN: 0959-6658            Impact factor:   4.313


  17 in total

1.  Concordance of increased B1 cell subset and lupus phenotypes in mice and humans is dependent on BLK expression levels.

Authors:  Ying-Yu Wu; Ina Georg; Alejandro Díaz-Barreiro; Nieves Varela; Bernard Lauwerys; Ramesh Kumar; Harini Bagavant; Mireia Castillo-Martín; Fadi El Salem; Concepción Marañón; Marta E Alarcón-Riquelme
Journal:  J Immunol       Date:  2015-05-13       Impact factor: 5.422

2.  Lack of galectin-1 or galectin-3 alters B cell deletion and anergy in an autoantibody transgene model.

Authors:  Amy G Clark; Melissa L Weston; Mary H Foster
Journal:  Glycobiology       Date:  2013-04-01       Impact factor: 4.313

3.  Galectin-3 deficiency enhances type 2 immune cell-mediated myocarditis in mice.

Authors:  Marina Miletic Kovacevic; Nada Pejnovic; Slobodanka Mitrovic; Nemanja Jovicic; Ivica Petrovic; Nebojsa Arsenijevic; Miodrag L Lukic; Biljana Ljujic
Journal:  Immunol Res       Date:  2018-08       Impact factor: 2.829

Review 4.  Galectin-3 in autoimmunity and autoimmune diseases.

Authors:  Felipe L de Oliveira; Mariele Gatto; Nicola Bassi; Roberto Luisetto; Anna Ghirardello; Leonardo Punzi; Andrea Doria
Journal:  Exp Biol Med (Maywood)       Date:  2015-07-03

5.  Immunomodulation of Homeopathic Thymulin 5CH in a BCG-Induced Granuloma Model.

Authors:  Leoni Villano Bonamin; Cesar Sato; Ruggero Zalla Neto; Graziela Morante; Thayná Neves Cardoso; Fabiana Rodrigues de Santana; Cideli de Paula Coelho; Lika Osugui; Ana Flavia Popi; Elizabeth Cristina Perez Hurtado; Mario Mariano
Journal:  Evid Based Complement Alternat Med       Date:  2013-01-28       Impact factor: 2.629

6.  Lack of galectin-3 disturbs mesenteric lymph node homeostasis and B cell niches in the course of Schistosoma mansoni infection.

Authors:  Felipe L Oliveira; Camila Brand; Adelzon A Paula; Kátia D Arcanjo; Daniel K Hsu; Fu-Tong Liu; Christina M Takiya; Radovan Borojevic; Roger Chammas; Márcia C El-Cheikh
Journal:  PLoS One       Date:  2011-05-06       Impact factor: 3.240

7.  The bone marrow compartment is modified in the absence of galectin-3.

Authors:  C Brand; F L Oliveira; L Ricon; M L Fermino; L C Boldrini; D K Hsu; F T Liu; R Chammas; R Borojevic; M Farina; M C El-Cheikh
Journal:  Cell Tissue Res       Date:  2011-11-27       Impact factor: 5.249

Review 8.  Extracellular galectin-3 in tumor progression and metastasis.

Authors:  Anneliese Fortuna-Costa; Angélica M Gomes; Eliene O Kozlowski; Mariana P Stelling; Mauro S G Pavão
Journal:  Front Oncol       Date:  2014-06-16       Impact factor: 6.244

9.  Increased NHC Cells in the Peritoneal Cavity of Plasmacytoma Susceptible BALB/c Mouse.

Authors:  Berenice Sánchez-González; Francisco Javier García-Vázquez; José Eduardo Farfán-Morales; Luis Antonio Jiménez-Zamudio
Journal:  Mediators Inflamm       Date:  2015-10-04       Impact factor: 4.711

10.  Differential development of oil granulomas induced by pristane injection in galectin-3 deficient mice.

Authors:  Camila Brand; Thayse Pinheiro da Costa; Emerson Soares Bernardes; Camila Maria Longo Machado; Leonardo Rodrigues Andrade; Roger Chammas; Felipe Leite de Oliveira; Márcia Cury El-Cheikh
Journal:  BMC Immunol       Date:  2015-11-14       Impact factor: 3.615

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.